Verrica Pharmaceuticals Inc. (VRCA) Free Cash Flow
Verrica Pharmaceuticals Inc. (VRCA) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2018-12-31 | -$18.65M |
| 2019-12-31 | -$28.09M |
| 2020-12-31 | -$31.68M |
| 2021-12-31 | -$28.46M |
| 2022-12-31 | -$18.95M |
| 2023-12-31 | -$38.94M |
| 2024-12-31 | -$60.95M |
| 2025-12-31 | -$17.63M |
How VRCA compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| SPRO | Spero Therapeutics Inc. | -$12.62M |
| NERV | — | -$13.51M |
| MYGN | Myriad Genetics Inc. | -$25.60M |
| DMAC | DiaMedica Therapeutics Inc. | -$29.10M |
| ATOS | Atossa Therapeutics Inc. | -$29.79M |
These are five companies in the same sector as VRCA with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Verrica Pharmaceuticals Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("VRCA", 2025, "")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | VRCA | $3.56 | -4.30% | 0.02M |
| 3 | ||||
| 4 | ||||
| 5 |